Published date: 20 March 2017
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
AIDS-prevention kits - 33141622
Location of contract
London
Value of contract
£72,000 to £80,000
Procurement reference
tender_126845/574134
Published date
20 March 2017
Closing date
28 February 2017
Contract start date
10 March 2017
Contract end date
9 March 2018
Contract type
Supply contract
Procedure type
Other:
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Under PHE Microbiology Framework Lot 2 Development, Public Health England awarded contract for the provision of HIV-1 LAg Avidity kits to Sedia Biosciences Corporation.
These kits will be used as part of the PHE- NIS national surveillance of New HIV Diagnosis. This assay manufactured by Sedia has been developed by the US Centers for Disease Control and Prevention (CDC). As a result, the assay has been licensed to this company by the US CDC and it has undergone independent evaluation by the Consortium for the evaluation and performance of HIV Incidence assays.
Sedia Biosciences Corporation is the sole manufacturer of these kits being specifically manufactured for the purpose of identifying recent infection as it has been shown to have the lowest false recent rate and an acceptable mean duration of recency.
Award information
Awarded date
28 February 2017
Contract start date
10 March 2017
Contract end date
9 March 2018
Total value of contract
£72,000
This contract was awarded to 1 supplier.
Sedia Biosciences Corporation
Address
4900 NE 122nd Ave, Portland, OR 97230, USA
Reference
None
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
Titi Agbo
Address
61 Colindale Avenue
Colindale
NW9 5EQ
England
Share this notice
Closing: 28 February 2017
All content is available under the
